Bardash Y - Search Results

1

The effect of race in head and neck cancer: A meta-analysis controlling for socioeconomic status.

Russo DP, Tham T, Bardash Y, Kraus D. Russo DP, et al. Among authors: bardash y. Am J Otolaryngol. 2020 Nov-Dec;41(6):102624. doi: 10.1016/j.amjoto.2020.102624. Epub 2020 Jun 24. Am J Otolaryngol. 2020. PMID: 32663732

2

The red cell distribution width as a prognostic indicator in upper aerodigestive tract (UADT) cancer: A systematic review and meta-analysis.

Tham T, Bardash Y, Teegala S, Herman WS, Costantino PD. Tham T, et al. Among authors: bardash y. Am J Otolaryngol. 2018 Jul-Aug;39(4):453-458. doi: 10.1016/j.amjoto.2018.04.013. Epub 2018 Apr 21. Am J Otolaryngol. 2018. PMID: 29699714 Review.

3

Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis.

Tham T, Bardash Y, Herman SW, Costantino PD. Tham T, et al. Among authors: bardash y. Head Neck. 2018 Nov;40(11):2546-2557. doi: 10.1002/hed.25324. Epub 2018 May 14. Head Neck. 2018. PMID: 29761587

4

Is human papillomavirus and p16 expression associated with survival outcomes in nasopharyngeal cancer?: A systematic review and meta-analysis.

Tham T, Teegala S, Bardash Y, Herman SW, Costantino P. Tham T, et al. Among authors: bardash y. Am J Otolaryngol. 2018 Nov-Dec;39(6):764-770. doi: 10.1016/j.amjoto.2018.07.005. Epub 2018 Jul 11. Am J Otolaryngol. 2018. PMID: 30029797 Review.

5

The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis.

Van der Elst S, Bardash Y, Wotman M, Kraus D, Tham T. Van der Elst S, et al. Among authors: bardash y. Head Neck. 2021 Nov;43(11):3608-3617. doi: 10.1002/hed.26868. Epub 2021 Sep 15. Head Neck. 2021. PMID: 34525238

6

Platelet-Lymphocyte Ratio as a Predictor of Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Bardash Y, Olson C, Herman W, Khaymovich J, Costantino P, Tham T. Bardash Y, et al. Oncol Res Treat. 2019;42(12):665-677. doi: 10.1159/000502750. Epub 2019 Sep 24. Oncol Res Treat. 2019. PMID: 31550732

7

Anaphylactoid hypersensitivity reaction from intra-arterial cetuximab: Clinical considerations and management.

Bardash Y, Tham T, Olson C, Khaymovich J, Costantino P. Bardash Y, et al. SAGE Open Med Case Rep. 2019 Jan 12;7:2050313X18823447. doi: 10.1177/2050313X18823447. eCollection 2019. SAGE Open Med Case Rep. 2019. PMID: 30728973 Free PMC article.

8

Outcomes of Stage III NSCLC with occult primary vs. known primary lesions.

Romesser PB, Bardash Y, Buonocore D, Chaft JE, Huang J, Jones DR, Rimner A, Wu AJ. Romesser PB, et al. Among authors: bardash y. Lung Cancer. 2019 Jan;127:34-36. doi: 10.1016/j.lungcan.2018.11.019. Epub 2018 Nov 17. Lung Cancer. 2019. PMID: 30642548 Free PMC article.

9

Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease.

de Cos M, Mosoyan G, Chauhan K, Troost JP, Wong JS, Lefferts S, Morgan P, Meliambro K, Egerman M, Ray J, Parker T, Levine D, Seshan S, Bardash Y, Horowitz B, Kent CA, Shaw MM, Perlman A, Moledina DG, Coca SG, Campbell KN. de Cos M, et al. Among authors: bardash y. Am J Kidney Dis. 2024 Mar 5:S0272-6386(24)00630-9. doi: 10.1053/j.ajkd.2024.01.520. Online ahead of print. Am J Kidney Dis. 2024. PMID: 38452919 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page